Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.
Sielecki
T M
TM
The DuPont Pharmaceuticals Company, P.O. Box 80500, Wilmington, Delaware 19880-0500, USA.
Boylan
J F
JF
Benfield
P A
PA
Trainor
G L
GL
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular
D004791:Enzyme Inhibitors; D018844:Cyclin-Dependent Kinases